Streamlining the generation of an osteogenic graft by 3D culture of unprocessed bone marrow on ceramic scaffolds

Journal of Tissue Engineering and Regenerative Medicine

Volumn 6, Issue 2, 2012, Pages 103-112

  Chatterjea, Anindita ^a   Renard, Auke J S ^b   Jolink, Christel ^c   van Blitterswijk, Clemens A ^a   de Boer, Jan ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

^c Laboratorium Pathologie Oost Nederland   (Netherlands)

Author keywords

3D culture; Bone tissue engineering; Mesenchymal stromal cells; Osteogenic grafts; Translational research; Unprocessed bone marrow

Indexed keywords

BIOMATERIALS; BIOREACTORS; BONE; CALCIUM PHOSPHATE; CELL ENGINEERING; ENDOTHELIAL CELLS; SCAFFOLDS (BIOLOGY); TISSUE CULTURE;

3-D CULTURES; BONE MARROW; BONE TISSUE ENGINEERING; CERAMIC SCAFFOLDS; DIRECT-SEEDING; MESENCHYMAL STROMAL CELLS; OSTEOGENIC; OSTEOGENIC GRAFT; TRANSLATIONAL RESEARCH; UNPROCESSED BONE MARROW;

CERAMIC MATERIALS;

CALCIUM PHOSPHATE CERAMIC; TISSUE SCAFFOLD;

ACETABULUM; ADULT; AGED; ARTICLE; BIOREACTOR; BONE MARROW CULTURE; BONE TISSUE; CELL COUNT; CELL GROWTH; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALE; MESENCHYMAL STROMA CELL; MULTINUCLEAR CELL; NUDE MOUSE; OSTEOGENIC GRAFT; POROSITY; PRIORITY JOURNAL; STROMA CELL; SURFACE PROPERTY; TISSUE ENGINEERING; TISSUE EXPANSION; TISSUE GRAFT;

EID: 84856239799     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.403     Document Type: Article

References (45)

1. Abbott A. 2003; Cell culture: biology's new dimension. Nature 424: 870-872.
2. Alves H, Munoz-Najar U, de Wit J, et al. 2009; A link between the accumulation of DNA damage and loss of multipotency of human mesenchymal stromal cells. J Cell Mol Med 14(12): 2729-2738.
3. Banfi A, Muraglia A, Dozin B, et al. 2000; Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol 28: 707-715.
4. Bianco P, Riminucci M, Gronthos S, et al. 2001; Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19: 180-192.
5. Both SK, van der Muijsenberg AJ, van Blitterswijk CA, et al. 2007; A rapid and efficient method for expansion of human mesenchymal stem cells. Tissue Eng 13: 3-9.
6. Braccini A, Wendt D, Farhadi J, et al. 2007; The osteogenicity of implanted engineered bone constructs is related to the density of clonogenic bone marrow stromal cells. J Tissue Eng Regen Med 1: 60-65.
7. Braccini A, Wendt D, Jaquiery C, et al. 2005; Three-dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells 23: 1066-1072.
8. D'Ippolito G, Schiller PC, Ricordi C, et al. 1999; Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 14: 1115-1122.
9. Diederichs S, Roker S, Marten D, et al. 2009; Dynamic cultivation of human mesenchymal stem cells in a rotating bed bioreactor system based on the Z RP platform. Biotechnol Prog 25: 1762-1771.
10. Dominici M, Le Blanc K, Mueller I, et al. 2006; Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
11. Fennema EM, Renard AJ, Leusink A, et al. 2009; The effect of bone marrow aspiration strategy on the yield and quality of human mesenchymal stem cells. Acta Orthop 80: 618-621.
12. Fernandes H, Mentink A, Bank R, et al. 2010; Endogenous collagen influences differentiation of human multipotent mesenchymal stromal cells. Tissue Eng A 16(5): 1693-1702.
13. Friedenstein AJ, Chailakhjan RK, Lalykina KS. 1970; The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3: 393-403.
14. Friedenstein AJ, Chailakhyan RK, Gerasimov UV. 1987; Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20: 263-272.
15. Frohlich M, Grayson WL, Marolt D, et al. 2010; Bone grafts engineered from human adipose-derived stem cells in perfusion bioreactor culture. Tissue Eng A 16: 179-189.
16. Gan Y, Dai K, Zhang P, et al. 2008; The clinical use of enriched bone marrow stem cells combined with porous β-tricalcium phosphate in posterior spinal fusion. Biomaterials 29: 3973-3982.
17. Haynesworth SE, Goshima J, Goldberg VM, et al. 1992; Characterization of cells with osteogenic potential from human marrow. Bone 13: 81-88.
18. Hu JZ, Zhang ZY, Zhao J, et al. 2009; An ectopic study of tissue-engineered bone with Nell-1 gene modified rat bone marrow stromal cells in nude mice. Chin Med J (Engl) 122: 972-979.
19. Janssen FW, Oostra J, Oorschot A, et al. 2006; A perfusion bioreactor system capable of producing clinically relevant volumes of tissue-engineered bone: in vivo bone formation showing proof of concept. Biomaterials 27: 315-323.
20. Janssen FW, van Dijkhuizen-Radersma R, Van Oorschot A, et al. 2010; Human tissue-engineered bone produced in clinically relevant amounts using a semi-automated perfusion bioreactor system: a preliminary study. J Tissue Eng Regen Med 4: 12-24.
21. Kadiyala S. 1997; Culture-expanded, Bone marrow-derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect. Tissue Eng 3(2): 173-185.
22. Kruyt MC, de Bruijn JD, Wilson CE, et al. 2003; Viable osteogenic cells are obligatory for tissue-engineered ectopic bone formation in goats. Tissue Eng 9: 327-336.
23. Kruyt MC, van Gaalen SM, Oner FC, et al. 2004; Bone tissue engineering and spinal fusion: the potential of hybrid constructs by combining osteoprogenitor cells and scaffolds. Biomaterials 25: 1463-1473.
24. Lund AW, Yener B, Stegemann JP, et al. 2009; The natural and engineered 3D microenvironment as a regulatory cue during stem cell fate determination. Tissue Eng B Rev 15: 371-380.
25. Martin I, Smith T, Wendt D. 2009; Bioreactor-based roadmap for the translation of tissue engineering strategies into clinical products. Trends Biotechnol 27: 495-502.
26. Meijer GJ, de Bruijn JD, Koole R, et al. 2007; Cell-based bone tissue engineering. PLoS Med 4: e9.
27. Meijer GJ, de Bruijn JD, Koole R, et al. 2008; Cell based bone tissue engineering in jaw defects. Biomaterials 29: 3053-3061.
28. Mendes SC, Tibbe JM, Veenhof M, et al. 2002; Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng 8: 911-920.
29. Oyajobi BO, Lomri A, Hott M, et al. 1999; Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow stroma using STRO-1 monoclonal antibody. J Bone Miner Res 14: 351-361.
30. Pittenger MF, Mackay AM, Beck SC, et al. 1999; Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
31. Quirici N, Soligo D, Bossolasco P, et al. 2002; Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 30: 783-791.
32. Roldan JC, Detsch R, Schaefer S, et al. 2010; Bone formation and degradation of a highly porous biphasic calcium phosphate ceramic in presence of BMP-7, VEGF and mesenchymal stem cells in an ectopic mouse model. J Craniomaxillofac Surg 38(6): 423-430.
33. Sailon AM, Allori AC, Davidson EH, et al. 2009; A novel flow-perfusion bioreactor supports 3D dynamic cell culture. J Biomed Biotechnol. [Epub ahead of print]. PMID: 20037739.
34. Salgado AJ, Coutinho OP, Reis RL 2004; Bone tissue engineering: state of the art and future trends. Macromol Biosci 4: 743-765.
35. Scaglione S, Braccini A, Wendt D, et al. 2006; Engineering of osteoinductive grafts by isolation and expansion of ovine bone marrow stromal cells directly on 3D ceramic scaffolds. Biotechnol Bioeng 93: 181-187.
36. Siddappa R, Licht R, van Blitterswijk C, et al. 2007; Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 25: 1029-1041.
37. Siddappa R, Martens A, Doorn J, et al. 2008; cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci USA 105: 7281-7286.
38. Sikavitsas VI, Bancroft GN, Mikos AG. 2002; Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J Biomed Mater Res 62: 136-148.
39. Song K, Liu T, Cui Z, et al. 2008; Three-dimensional fabrication of engineered bone with human bio-derived bone scaffolds in a rotating wall vessel bioreactor. J Biomed Mater Res A 86: 323-332.
40. Tasso R, Fais F, Reverberi D, et al. 2010; The recruitment of two consecutive and different waves of host stem/progenitor cells during the development of tissue-engineered bone in a murine model. Biomaterials 31: 2121-2129.
41. Timmins NE, Scherberich A, Fruh JA, et al. 2007; Three-dimensional cell culture and tissue engineering in a T-CUP (tissue culture under perfusion). Tissue Eng 13: 2021-2028.
42. Viateau V, Guillemin G, Bousson V, et al. 2007; Long-bone critical-size defects treated with tissue-engineered grafts: a study on sheep. J Orthop Res 25: 741-749.
43. Wendt D, Marsano A, Jakob M, et al. 2003; Oscillating perfusion of cell suspensions through three-dimensional scaffolds enhances cell seeding efficiency and uniformity. Biotechnol Bioeng 84: 205-214.
44. Wongchuensoontorn C, Liebehenschel N, Schwarz U, et al. 2009; Application of a new chair-side method for the harvest of mesenchymal stem cells in a patient with nonunion of a fracture of the atrophic mandible-a case report. J Craniomaxillofac Surg 37: 155-161.
45. Yuan H, Van Den Doel M, Li S, et al. 2002; A comparison of the osteoinductive potential of two calcium phosphate ceramics implanted intramuscularly in goats. J Mater Sci Mater Med 13: 1271-1275.